Intelligent bio solutions to present at the ld micro invitational xiv investor conference on april 9 in nyc

New york, march 26, 2024 (globe newswire) -- intelligent bio solutions inc. ("inbs" or the "company") (nasdaq: inbs), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that president and ceo, harry simeonidis, and cfo, spiro sakiris, are scheduled to present at the ld micro invitational xiv investor conference to be held on april 8-9, 2024 in new york city.
INBS Ratings Summary
INBS Quant Ranking